References:
- Otto, C. M., et al. (2021). ”2020 ACC/AHA Guideline for the Management
of Patients With Valvular Heart Disease: A Report of the American
College of Cardiology/American Heart Association Joint Committee on
Clinical Practice Guidelines.” Circulation 143(5): e72-e22
- Alavi SH, Groves EM, Kheradvar A. The effects of transcatheter valve
crimping on pericardial leaflets. Ann Thorac Surg 2014; 97:1260–6.
- Doff B. McElhinney, Jamil A. Aboulhosn, et al., Mid-Term Valve-Related
Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring
Replacement, Journal of the American College of Cardiology
- Yoon S-H, Whisenant BK, Bleiziffer S, et al.Outcomes of transcatheter
mitral valve replacement for degenerated bioprostheses, failed
annuloplasty rings, and mitral annular calcification. Eur Heart J
2019; 40:441–51
- Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical
outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc
Interv 2015;8: e001779
- A.C. Egbe, S.V. Pislaru, P.A. Pellikka, et al. Bioprosthetic valve
thrombosis versus structural failure: clinical and echocardiographic
predictors J Am Coll Cardiol, 66 (2015), pp. 2285-2294
- Rishi Puri, Vincent Auffret, Josep Rodés-Cabau, Bioprosthetic Valve
Thrombosis, Journal of the American College of Cardiology, Volume 69,
Issue 17,2017,pp 2193-2211,
- Adi Butnaru, Joseph Shaheen, et al. Valve thrombosis following
transcatheter aortic valve implantation: a systematic review. Rev Esp
Cardiol (Engl Ed) 2015; 68:198–204.
- Jose J, Sulimov DS, et al. Clinical Bioprosthetic Heart Valve
Thrombosis After Transcatheter Aortic Valve Replacement: Incidence,
Characteristics, and Treatment Outcomes. JACC Cardiovasc Interv. 2017
Apr 10;10(7):686-697. doi: 10.1016/j.jcin.2017.01.045. PMID: 28385406.
- Marwan M, Mekkhala N, Göller M, Röther J, Bittner D, Schuhbaeck A,
Hell M, Muschiol G, Kolwelter J, Feyrer R, Schlundt C, Achenbach S,
Arnold M. Leaflet thrombosis following transcatheter aortic valve
implantation. J Cardiovasc Comput Tomogr. 2018 Jan-Feb;12(1):8-13.
doi: 10.1016/j.jcct.2017.11.002. Epub 2017 Nov 9. PMID: 29195844.
- Maryam Shojaeifard, Negar Sarrafirad, Sajad Erami, et al. Management
and Clinical Outcomes in Patients with Mechanical Tricuspid Valve
Thrombosis. Authorea. June 08, 2020.
- Özkan, M., et al. (2013). ”Comparison of Different TEE-Guided
Thrombolytic Regimens for Prosthetic Valve Thrombosis.” JACC:
Cardiovascular Imaging 6(2): 206-216.
- Nathem Akhras, Hani Al Sergani, et al. Thrombolytic Therapy as the
Management of Mitral Transcatheter Valve-in-Valve Implantation Early
Thrombosis, Heart, Lung and Circulation, Volume 25, Issue 5, 2016
- Özkan M, Gündüz S, et al., Ultraslow thrombolytic therapy: A novel
strategy in the management of Prosthetic Mechanical valve Thrombosis
and the predictors of outcome: The Ultra-slow PROMETEE trial. Am Heart
J. 2015 Aug;170(2):409-18. doi: 10.1016/j.ahj.2015.04.025.